Canmab Trastuzumab 440 mg Injection

Canmab Trastuzumab 440 mg Injection

59981 INR

Product Details:

  • Drug Type Injection
  • Physical Form Liquid
  • Function Cancer Treatment
  • Dosage 440 mg
  • Suitable For Teenagers, Women, Adults, Aged Person, Suitable For All
  • Storage Instructions Store In a Cool Palace
  • Supply Ability : 100 Box Per Week
  • Click to view more
X

Price And Quantity

  • 59981 INR
  • 10 Box

Product Specifications

  • 440 mg
  • Injection
  • Teenagers, Women, Adults, Aged Person, Suitable For All
  • Cancer Treatment
  • Liquid
  • Store In a Cool Palace

Trade Information

  • Cash Advance (CA), Cash in Advance (CID), Cheque, Letter of Credit at Sight (Sight L/C), Telegraphic Transfer (T/T), Western Union
  • 100 Box Per Week
  • 1 Week
  • Asia, Australia, Central America, North America, South America, Eastern Europe, Western Europe, Middle East, Africa
  • All India

Product Description

WHAT ARE THE USES OF TRASTUZUMAB 440 MG INJECTION ?

Canmab is a cancer medication that interferes with the growth and spread of cancer cells in the body. It is mainly used to treat certain types of breast cancer or stomach cancer.

WHAT ARE THE POSSIBLE SIDE-EFFECTS OF CANMAB TRASTUZUMAB 440MG INJECTION ?

Some side effects may occur during the injection. Speak your doctor right away if you feel dizzy, nauseated, light-headed, weak, short of breath, or if you have a headache, fever, chills, sudden chest pain, wheezing, dry cough, hives, or swelling of your face, lips, tongue, or throat.

Get emergency medical help if you have signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat.

This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects.

 

Enter Buying Requirement Details
Email Id
Mobile number

Other Products in 'Anticancer Drugs' category



Back to top
3S CORPORATION All Rights Reserved.(Terms of Use)
Developed and Managed by Infocom Network Private Limited.